Lasa Supergenerics Limited (LASA) — Announcement | 25 August 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Whole-time Director Ganesh Potdar resigns effective 25 August 2026
💡 Investor Takeaway
His departure removes a key executive without stated operational or financial impact.

Lasa Supergenerics announced the resignation of Whole-time Director Ganesh Potdar effective 25 August 2026, citing personal commitments, with no material reason beyond those stated, following SEBI listing regulations.

📄 View Original Announcement (PDF)

About Lasa Supergenerics Limited (LASA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹31.41 Cr ROE: -20.2% ROCE: -17.9%

View full LASA stock details →

📡 Get AI alerts when LASA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LASA — Free

📊 More LASA filings

See all LASA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LASA files new disclosures

Track LASA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track LASA — Free

Free account · 2 AI queries/day